Personalized Glaucoma Care Our Approach
At Princeton Eye Group, we believe glaucoma care should be individualized rather than following a one-size-fits-all approach. Our specialists work with each patient to develop a treatment plan that reflects the severity and rate of progression of their disease, their lifestyle, medication tolerance, and their personal goals and preferences. For some patients, interventional approaches such as earlier laser treatment or surgical intervention may offer meaningful advantages, including better long-term intraocular pressure control, reduced dependence on medications, or improved quality of life. We discuss the benefits and tradeoffs of each option so that treatment decisions align with both the clinical situation and the patient's comfort with risk.
As glaucoma specialists, we offer the full spectrum of modern treatment options—from medications to laser procedures and minimally invasive or traditional glaucoma surgery. Rather than relying on a predetermined treatment pathway, we tailor our recommendations to each patient's needs, recognizing that the right approach may change over time as the disease evolves.
Glaucoma Drop Management
Prescription eye drops are often an important part of controlling glaucoma and lowering intraocular pressure. We take a thoughtful, individualized approach to glaucoma drop management, with the goal of using the fewest medications necessary to achieve safe and effective pressure control. Whenever possible, we work to minimize the number of daily eye drops to reduce side effects, simplify treatment routines, and maximize quality of life.
Sustained-Release Glaucoma Medications
For appropriate patients, sustained-release glaucoma medications such as iDose® and Durysta® can provide an alternative to daily eye drops. These treatments are designed to deliver medication gradually over an extended period, helping lower intraocular pressure while reducing the burden of remembering and administering drops every day. By minimizing the need for frequent eye-drop use, sustained-release therapies may help reduce medication-related side effects, simplify daily routines, and improve quality of life. We carefully consider each patient’s glaucoma, treatment goals, and overall health when determining whether a sustained-release medication is an appropriate option.
Glaucoma Laser Treatment
Laser procedures such as selective laser trabeculoplasty (SLT) offer an effective, non-incisional approach to lowering intraocular pressure, either as a first-line treatment or as a complement to medications. Laser treatment is performed in-office and requires no recovery time.
Laser peripheral iridotomy (LPI) is a minimally invasive laser procedure used to treat or prevent angle-closure glaucoma. By creating a tiny opening in the iris, LPI improves the flow of fluid within the eye and helps relieve or prevent blockage of the drainage angle. The procedure is typically performed in the office and takes only a few minutes, with little to no downtime.
Minimally Invasive Glaucoma Surgery (MIGS)
MIGS procedures use micro-scale surgical techniques to improve fluid drainage from the eye with a favorable safety profile and faster recovery than traditional surgery. Many MIGS procedures can be performed at the time of cataract surgery, making them an efficient option for patients managing both conditions simultaneously.
Glaucoma Surgical Treatment
For patients with advanced glaucoma or disease that has not responded adequately to medications and laser therapy, surgical options including trabeculectomy, tube shunt surgery, and the XEN gel stent provide more aggressive and sustained pressure reduction to protect the optic nerve from further damage.
In some situations, glaucoma can cause dangerously high intraocular pressure that requires urgent surgical intervention. When pressure needs to be lowered quickly to protect the optic nerve and preserve vision, we provide timely evaluation and surgical treatment tailored to the individual patient’s condition.